MONTPELIER HEALTH CENTRE — All Prescriptions & Medications — Page 9
Practice Code: L81012 | BRISTOL, BS6 5PT
Showing results 401-450 of 566
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Enoxaparin | 31 | 876 | £3.7K | +51.2% ▲ |
| Rasagiline mesilate | 31 | 1,736 | £986 | -16.5% ▼ |
| Rivastigmine | 31 | 1,194 | £637 | -54.9% ▼ |
| 31 | 320 | £39 | -17.6% ▼ | |
| Valproic acid | 30 | 2,280 | £762 | -65.5% ▼ |
| Flupentixol hydrochloride | 30 | 2,606 | £126 | -8.4% ▼ |
| Orlistat | 30 | 3,360 | £807 | -63.6% ▼ |
| Ciprofloxain/dexameth | 30 | 195 | £227 | -2.3% ▼ |
| Chlorhexidine gluconate | 30 | 8,650 | £67 | +36.6% ▲ |
| 29 | 1,060 | £4.6K | -35.9% ▼ | |
| Pravastatin sodium | 28 | 1,848 | £91 | -91.4% ▼ |
| Phenobarbital | 28 | 2,928 | £139 | -8.9% ▼ |
| Etodolac | 28 | 648 | £321 | +1.1% vs avg |
| Other individually formulated bought in preparations | 28 | 814 | £218 | -14.3% ▼ |
| Metoprolol tartrate | 27 | 1,400 | £280 | -46.8% ▼ |
| Potassium chloride | 27 | 15.2K | £5.9K | +44.4% ▲ |
| Adapalene | 27 | 2,250 | £781 | +23.4% ▲ |
| 27 | 2,613 | £4.3K | -20.1% ▼ | |
| Acrivastine | 26 | 2,424 | £699 | +111.1% ▲ |
| Bupropion hydrochloride | 26 | 1,580 | £1.0K | +140.6% ▲ |
| Etonogestrel/ethinylestradiol | 26 | 80 | £779 | +392.8% ▲ |
| Anastrozole | 26 | 1,512 | £56 | -71.4% ▼ |
| Dexamethasone | 26 | 237 | £295 | -56.5% ▼ |
| Brimonidine tartrate | 26 | 265 | £135 | -34.9% ▼ |
| Methyldopa | 25 | 1,736 | £387 | +46.8% ▲ |
| Glyceryl trinitrate | 24 | 780 | £971 | +80.6% ▲ |
| Dexamethasone | 24 | 730 | £231 | -23.0% ▼ |
| Medroxyprogesterone acetate | 24 | 1,657 | £331 | -37.3% ▼ |
| Combined ethinylestradiol 35mcg | 24 | 2,520 | £167 | +92.6% ▲ |
| 24 | 5,300 | £921 | -24.4% ▼ | |
| Midazolam hydrochloride | 23 | 85 | £1.9K | +59.6% ▲ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 23 | 107.5K | £2.4K | +85.5% ▲ |
| 23 | 168 | £39 | -35.5% ▼ | |
| 23 | 85 | £3.5K | -35.6% ▼ | |
| Modafinil | 22 | 1,500 | £262 | +5.5% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 22 | 570 | £42 | +46.4% ▲ |
| Zinc oxide | 22 | 5,905 | £182 | +9.4% ▲ |
| Aclidinium bromide | 21 | 36 | £1.1K | -20.9% ▼ |
| Flupentixol hydrochloride | 21 | 588 | £80 | -4.3% ▼ |
| Guanfacine | 21 | 1,400 | £2.7K | -18.3% ▼ |
| Glucagon | 21 | 29 | £335 | +38.0% ▲ |
| Other compound vitamin/mineral formulation preparations | 21 | 1,122 | £103 | -34.5% ▼ |
| Fludroxycortide | 21 | 58 | £1.3K | +99.2% ▲ |
| Pimecrolimus | 21 | 1,300 | £756 | +24.0% ▲ |
| 21 | 21 | £49 | -35.2% ▼ | |
| Midodrine hydrochloride | 20 | 3,096 | £1.0K | -58.9% ▼ |
| Fenofibrate | 20 | 622 | £66 | -79.3% ▼ |
| Itraconazole | 20 | 702 | £284 | +49.1% ▲ |
| Fludrocortisone acetate | 20 | 1,272 | £177 | -81.0% ▼ |
| Cabergoline | 20 | 160 | £372 | +29.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.